ChemoMetec (Denmark) Performance
| CHEMM Stock | DKK 534.00 8.00 1.48% |
ChemoMetec has a performance score of 5 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.69, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, ChemoMetec's returns are expected to increase less than the market. However, during the bear market, the loss of holding ChemoMetec is expected to be smaller as well. ChemoMetec AS right now shows a risk of 2.86%. Please confirm ChemoMetec AS standard deviation, expected short fall, period momentum indicator, as well as the relationship between the maximum drawdown and rate of daily change , to decide if ChemoMetec AS will be following its price patterns.
Risk-Adjusted Performance
Modest
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in ChemoMetec AS are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak fundamental indicators, ChemoMetec may actually be approaching a critical reversion point that can send shares even higher in April 2025. ...more
| Begin Period Cash Flow | 150.1 M | |
| Total Cashflows From Investing Activities | -56 M |
ChemoMetec |
ChemoMetec Relative Risk vs. Return Landscape
If you would invest 48,760 in ChemoMetec AS on December 22, 2024 and sell it today you would earn a total of 4,640 from holding ChemoMetec AS or generate 9.52% return on investment over 90 days. ChemoMetec AS is generating 0.191% of daily returns and assumes 2.8566% volatility on return distribution over the 90 days horizon. Simply put, 25% of stocks are less volatile than ChemoMetec, and 97% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
ChemoMetec Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for ChemoMetec's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as ChemoMetec AS, and traders can use it to determine the average amount a ChemoMetec's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0669
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CHEMM | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.86 actual daily | 25 75% of assets are more volatile |
Expected Return
| 0.19 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average ChemoMetec is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ChemoMetec by adding it to a well-diversified portfolio.
ChemoMetec Fundamentals Growth
ChemoMetec Stock prices reflect investors' perceptions of the future prospects and financial health of ChemoMetec, and ChemoMetec fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ChemoMetec Stock performance.
| Return On Equity | 0.49 | |||
| Return On Asset | 0.31 | |||
| Profit Margin | 0.39 % | |||
| Operating Margin | 0.50 % | |||
| Current Valuation | 14.38 B | |||
| Shares Outstanding | 17.4 M | |||
| Price To Earning | 197.96 X | |||
| Price To Book | 40.83 X | |||
| Price To Sales | 32.10 X | |||
| Revenue | 428.39 M | |||
| EBITDA | 224.86 M | |||
| Cash And Equivalents | 209.02 M | |||
| Cash Per Share | 12.01 X | |||
| Total Debt | 6.79 M | |||
| Debt To Equity | 0.02 % | |||
| Book Value Per Share | 26.27 X | |||
| Cash Flow From Operations | 176.86 M | |||
| Earnings Per Share | 10.15 X | |||
| Total Asset | 501.27 M | |||
| Retained Earnings | 36 M | |||
| Current Asset | 33 M | |||
| Current Liabilities | 8 M | |||
About ChemoMetec Performance
By analyzing ChemoMetec's fundamental ratios, stakeholders can gain valuable insights into ChemoMetec's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if ChemoMetec has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if ChemoMetec has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
ChemoMetec AS engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company was founded in 1997 and is headquartered in Allerd, Denmark. ChemoMetec operates under Medical Equipment classification in Denmark and is traded on Copenhagen Stock Exchange. It employs 155 people.Things to note about ChemoMetec AS performance evaluation
Checking the ongoing alerts about ChemoMetec for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for ChemoMetec AS help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Evaluating ChemoMetec's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate ChemoMetec's stock performance include:- Analyzing ChemoMetec's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ChemoMetec's stock is overvalued or undervalued compared to its peers.
- Examining ChemoMetec's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ChemoMetec's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ChemoMetec's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of ChemoMetec's stock. These opinions can provide insight into ChemoMetec's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for ChemoMetec Stock analysis
When running ChemoMetec's price analysis, check to measure ChemoMetec's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ChemoMetec is operating at the current time. Most of ChemoMetec's value examination focuses on studying past and present price action to predict the probability of ChemoMetec's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ChemoMetec's price. Additionally, you may evaluate how the addition of ChemoMetec to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |